← Every company

Immunitybio Inc SEC Filings

What Immunitybio Inc has told the SEC happened, by the 8-K items and forms it filed under: when it reported results, who joined or left, what it bought or sold, and whether its auditor or its accounts ever changed.

IBRX overview →
Filings on file
104
since Nov 10, 2016
Warning signs
1
latest Mar 19, 2025
Last results
Aug 4, 2026
8-K item 2.02
Industry
Biological Products, (No Diagnostic Substances)
SIC 2836

Newest first

Each label is a form type or an 8-K item as filed; each row links to the filing.

FiledWhat it reportsDocument
Aug 4, 2026
Quarterly report
10-Q
Read ↗
Aug 4, 2026
Results announced
8-K
Read ↗
Jun 10, 2026
Shareholder vote
8-K
Read ↗
May 18, 2026
Material agreement
8-K
Read ↗
May 7, 2026
Quarterly report
10-Q
Read ↗
May 7, 2026
Results announced
8-K
Read ↗
Apr 9, 2026
Results announced
8-K
Read ↗
Mar 31, 2026
Material agreementNew debt
8-K
Read ↗
Feb 23, 2026
Annual report
10-K
Read ↗
Feb 23, 2026
Results announced
8-K
Read ↗
Jan 26, 2026
Material agreement
8-K
Read ↗
Jan 15, 2026
Results announced
8-K
Read ↗
Dec 29, 2025
Material agreement
8-K
Read ↗
Dec 15, 2025
Executive or director change
8-K
Read ↗
Nov 5, 2025
Quarterly report
10-Q
Read ↗
Nov 5, 2025
Results announced
8-K
Read ↗
Aug 5, 2025
Quarterly report
10-Q
Read ↗
Aug 5, 2025
Results announced
8-K
Read ↗
Jul 25, 2025
Results announcedMaterial agreement
8-K
Read ↗
Jun 20, 2025
Executive or director changeShareholder vote
8-K
Read ↗
May 12, 2025
Quarterly report
10-Q
Read ↗
May 12, 2025
Results announced
8-K
Read ↗
Apr 15, 2025
Results announced
8-K
Read ↗
Apr 8, 2025
Material agreement
8-K
Read ↗
Mar 19, 2025
Auditor change
8-K
Read ↗
Mar 3, 2025
Annual report
10-K
Read ↗
Mar 3, 2025
Results announced
8-K
Read ↗
Feb 13, 2025
Executive or director change
8-K
Read ↗
Feb 7, 2025
Executive or director change
8-K
Read ↗
Dec 11, 2024
Material agreement
8-K
Read ↗
Nov 12, 2024
Quarterly report
10-Q
Read ↗
Nov 12, 2024
Results announced
8-K
Read ↗
Aug 12, 2024
Quarterly report
10-Q
Read ↗
Jul 18, 2024
Material agreement
8-K
Read ↗
Jun 12, 2024
Shareholder vote
8-K
Read ↗
May 9, 2024
Quarterly report
10-Q
Read ↗
Mar 19, 2024
Annual report
10-K
Read ↗
Feb 26, 2024
Executive or director change
8-K
Read ↗
Jan 2, 2024
Material agreementNew debtUnregistered share sale
8-K
Read ↗
Nov 9, 2023
Quarterly report
10-Q
Read ↗
Sep 11, 2023
Material agreementNew debtUnregistered share sale
8-K
Read ↗
Aug 8, 2023
Quarterly report
10-Q
Read ↗
Jul 21, 2023
Material agreement
8-K
Read ↗
Jun 14, 2023
Material agreementNew debtShareholder vote
8-K
Read ↗
May 11, 2023
Quarterly report
10-Q
Read ↗
Mar 31, 2023
Material agreementNew debt
8-K
Read ↗
Mar 1, 2023
Annual report
10-K
Read ↗
Feb 15, 2023
Material agreement
8-K
Read ↗
Feb 14, 2023
Results announced
8-K
Read ↗
Dec 12, 2022
Results announcedMaterial agreementNew debt
8-K
Read ↗
Nov 9, 2022
Quarterly report
10-Q
Read ↗
Sep 2, 2022
Material agreementNew debt
8-K
Read ↗
Aug 8, 2022
Quarterly report
10-Q
Read ↗
Jun 14, 2022
Shareholder vote
8-K
Read ↗
May 10, 2022
Quarterly report
10-Q
Read ↗
Mar 25, 2022
Executive or director change
8-K
Read ↗
Mar 1, 2022
Annual report
10-K
Read ↗
Feb 15, 2022
Acquisition or sale completedMaterial agreement
8-K
Read ↗
Jan 12, 2022
Material agreement
8-K
Read ↗
Dec 20, 2021
Material agreementNew debt
8-K
Read ↗
Nov 12, 2021
Quarterly report
10-Q
Read ↗
Sep 27, 2021
Material agreement
8-K
Read ↗
Sep 13, 2021
Results announced
8-K
Read ↗
Aug 13, 2021
Executive or director change
8-K
Read ↗
Aug 12, 2021
Quarterly report
10-Q
Read ↗
Jun 15, 2021
Shareholder vote
8-K
Read ↗
Jun 11, 2021
Results announcedShareholder vote
8-K
Read ↗
May 28, 2021
Material agreement
8-K
Read ↗
May 14, 2021
Quarterly report
10-Q
Read ↗
May 3, 2021
Results announcedMaterial agreement
8-K
Read ↗
Apr 1, 2021
Executive or director change
8-K
Read ↗
Mar 10, 2021
Executive or director changeAcquisition or sale completedNew debtShareholder vote
8-K
Read ↗
Mar 4, 2021
Annual report
10-K
Read ↗
Feb 10, 2021
Executive or director change
8-K
Read ↗
Feb 2, 2021
Merger vote or registration
DEFM14A
Read ↗
Jan 19, 2021
Merger vote or registration
S-4
Read ↗
Dec 22, 2020
Material agreement
8-K
Read ↗
Nov 9, 2020
Quarterly report
10-Q
Read ↗
Oct 26, 2020
Executive or director change
8-K
Read ↗
Aug 24, 2020
Material agreement
8-K
Read ↗
Aug 7, 2020
Quarterly report
10-Q
Read ↗
Jun 19, 2020
Executive or director change
8-K
Read ↗
Jun 12, 2020
Executive or director changeShareholder vote
8-K
Read ↗
May 27, 2020
Material agreement
8-K
Read ↗
May 11, 2020
Quarterly report
10-Q
Read ↗
Mar 25, 2020
Annual report
10-K
Read ↗
Nov 5, 2019
Quarterly report
10-Q
Read ↗
Aug 6, 2019
Quarterly report
10-Q
Read ↗
Jun 7, 2019
Executive or director changeShareholder vote
8-K
Read ↗
May 8, 2019
Quarterly report
10-Q
Read ↗
Mar 13, 2019
Annual report
10-K
Read ↗
Nov 7, 2018
Quarterly report
10-Q
Read ↗
Aug 6, 2018
Quarterly report
10-Q
Read ↗
Jun 13, 2018
Executive or director changeShareholder vote
8-K
Read ↗
May 7, 2018
Quarterly report
10-Q
Read ↗
Apr 17, 2018
Executive or director change
8-K
Read ↗
Mar 12, 2018
Annual report
10-K
Read ↗
Nov 7, 2017
Quarterly report
10-Q
Read ↗
Sep 22, 2017
Executive or director change
8-K
Read ↗
Aug 7, 2017
Quarterly report
10-Q
Read ↗
Jun 13, 2017
Shareholder vote
8-K
Read ↗
May 8, 2017
Quarterly report
10-Q
Read ↗
Mar 15, 2017
Annual report
10-K
Read ↗
Nov 10, 2016
Quarterly report
10-Q
Read ↗

Source: Immunitybio Inc's EDGAR filing history, the last ten years. The labels are the form types and 8-K item numbers the company filed under, not a reading of what it wrote — an item 5.02 can be a chief executive fired or a director retiring on schedule — so each row links to the filing.

More on IBRX

Related datasets